According to Hepion Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$49.29 M. In 2022 the company made an earning of -$45 M a decrease over its 2021 earnings that were of -$32.73 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$47.7 M | 6% |
2022 | -$45 M | 37.49% |
2021 | -$32.73 M | 61.27% |
2020 | -$20.3 M | 174.55% |
2019 | -$7.4 M | -31.28% |
2018 | -$10.76 M | |
2016 | -$21.35 M | 6.03% |
2015 | -$20.14 M | 265% |
2014 | -$5.52 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 124.77% | ๐บ๐ธ USA |